Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35781107566;107567;107568 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
N2AB34140102643;102644;102645 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
N2A3321399862;99863;99864 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
N2B2671680371;80372;80373 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
Novex-12684180746;80747;80748 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
Novex-22690880947;80948;80949 chr2:178528310;178528309;178528308chr2:179393037;179393036;179393035
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Ig-168
  • Domain position: 80
  • Structural Position: 164
  • Q(SASA): 0.208
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/S None None 1.0 D 0.794 0.833 0.478222008075 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.761 likely_pathogenic 0.7882 pathogenic -0.477 Destabilizing 1.0 D 0.735 prob.delet. D 0.591085417 None None I
G/C 0.9269 likely_pathogenic 0.9435 pathogenic -0.877 Destabilizing 1.0 D 0.8 deleterious D 0.631764233 None None I
G/D 0.9048 likely_pathogenic 0.9252 pathogenic -1.138 Destabilizing 1.0 D 0.846 deleterious D 0.584877692 None None I
G/E 0.9089 likely_pathogenic 0.9303 pathogenic -1.295 Destabilizing 1.0 D 0.834 deleterious None None None None I
G/F 0.9832 likely_pathogenic 0.9872 pathogenic -1.138 Destabilizing 1.0 D 0.834 deleterious None None None None I
G/H 0.9703 likely_pathogenic 0.9766 pathogenic -0.82 Destabilizing 1.0 D 0.805 deleterious None None None None I
G/I 0.974 likely_pathogenic 0.9782 pathogenic -0.541 Destabilizing 1.0 D 0.839 deleterious None None None None I
G/K 0.967 likely_pathogenic 0.9729 pathogenic -1.221 Destabilizing 1.0 D 0.833 deleterious None None None None I
G/L 0.9728 likely_pathogenic 0.9782 pathogenic -0.541 Destabilizing 1.0 D 0.828 deleterious None None None None I
G/M 0.9827 likely_pathogenic 0.9859 pathogenic -0.494 Destabilizing 1.0 D 0.799 deleterious None None None None I
G/N 0.9282 likely_pathogenic 0.9416 pathogenic -0.771 Destabilizing 1.0 D 0.8 deleterious None None None None I
G/P 0.9973 likely_pathogenic 0.9982 pathogenic -0.485 Destabilizing 1.0 D 0.855 deleterious None None None None I
G/Q 0.9364 likely_pathogenic 0.9503 pathogenic -1.095 Destabilizing 1.0 D 0.855 deleterious None None None None I
G/R 0.9287 likely_pathogenic 0.942 pathogenic -0.673 Destabilizing 1.0 D 0.862 deleterious D 0.595930514 None None I
G/S 0.5809 likely_pathogenic 0.6246 pathogenic -0.849 Destabilizing 1.0 D 0.794 deleterious D 0.58026476 None None I
G/T 0.9119 likely_pathogenic 0.9263 pathogenic -0.954 Destabilizing 1.0 D 0.831 deleterious None None None None I
G/V 0.944 likely_pathogenic 0.9537 pathogenic -0.485 Destabilizing 1.0 D 0.833 deleterious D 0.647379986 None None I
G/W 0.9638 likely_pathogenic 0.9694 pathogenic -1.321 Destabilizing 1.0 D 0.806 deleterious None None None None I
G/Y 0.9656 likely_pathogenic 0.9723 pathogenic -0.997 Destabilizing 1.0 D 0.833 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.